Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2000-09-05
2004-08-24
Jastrzab, Jeffrey R. (Department: 3762)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
Reexamination Certificate
active
06782291
ABSTRACT:
FIELD OF THE INVENTION
The present invention generally relates to an implantable cardiac stimulation device. The present invention is more particularly directed to such a device and method which provides automatic selection of evoked response sensing electrode configurations.
BACKGROUND OF THE INVENTION
Implantable cardiac stimulation devices are well known in the art. Such devices apply electrical stimulation pulses to one or more chambers of the heart. The energies of the applied stimulation pulses are selected so as to be above the pacing energy stimulation threshold of the respective heart chamber to cause the cardiac tissue of that chamber to depolarize. Depolarization of the cardiac tissue of the respective chamber in turn causes the respective chamber heart muscle to contract. In this manner, the required pumping action of the heart is sustained.
It is therefore desirable to ascertain the pacing energy stimulation threshold of a heart chamber to be paced. A pacing energy may then be selected which is above the threshold to assure reliable pacing.
When a pacing pulse is effective in causing depolarization or contraction of the heart muscle, it is referred to as “capture” of the heart. Conversely, when a pacing pulse is ineffective in causing depolarization or contraction of the heart muscle, it is referred to as “lack of capture” of the heart.
An electrogram (EGM), as is also well known in the art, is an electrical signal representing the electrical activity of a heart muscle. The electrical manifestation of lack of capture in a heart muscle is typically a negative deflection in the electrogram baseline. This is referred to as polarization (POL). The electrical manifestation of capture in a heart muscle typically an exaggerated biphasic deflection in the EGM. This is generally referred to as the evoked response plus polarization (ER+POL).
When a cardiac stimulation device performs a pacing energy stimulation threshold search or test, it applies a succession of test pacing pulses at a basic rate. The energy of each successive pacing pulse is reduced by a known amount and capture is verified following each pulse. Capture may be verified by detecting the evoked response.
Each stimulation includes a pair of pulses, a primary pulse and a subsequent backup pulse. The stimulation pulses of each pair are timed such that, if the primary pulse captures, the backup pulse will be delivered during the refractory period to provide a measure of polarization. The polarization waveform is subtracted from the evoked response plus polarization waveform to determine if capture occurred.
Sensing of evoked responses is therefore useful for capture verification and threshold assessment. Unfortunately, sensing of evoked responses is often difficult. Polarization after potentials tend to obscure the evoked responses when leads are used which have polarizing electrodes, such as electrodes formed of polarized platinum. Further, a number of leads, like active fixation screw-in leads continue to include electrodes formed of polarizing materials. Still further, leads that are retained for further use at device replacement tend be early generation leads having polarizing electrodes.
The present invention addresses the issues of sensing evoked responses. More specifically, as will be seen hereafter, the present invention provides for the automatic selection of the best evoked response sensing electrode configuration from among the most propitious evoked response sensing electrode configurations offered by a cardiac stimulation system.
SUMMARY OF THE INVENTION
The present invention provides an implantable cardiac stimulation device and method wherein pacing stimulation pulses are applied to a heart and evoked responses to the stimulation pulses are sensed utilizing an automatically selected evoked response sensing electrode configuration.
A plurality of available evoked response sensing electrode configurations are stored in a memory. A sensor control selects an evoked response sensing electrode configuration from among the stored configuration in response to the current pacing configuration. The pacing configuration may be defined by device type, pacing lead type, and/or electrode implant sites.
When more than one evoked response sensing electrode configuration is available for a given pacing configuration, each available evoked response sensing electrode configuration is evaluated by the measurement of a common sensing characteristic, such as signal-to-noise ratio. The evoked response sensing electrode configuration yielding the greatest sensing characteristic measurement is then selected and programmed into the device. Evoked response sensing electrode configurations may be selected for both ventricular and atrial evoked responses in accordance with the present invention.
The evoked response sensing electrode configuration evaluation is preferably implemented by a processor. When the measured sensing characteristic is signal-to-noise ratio, the processor is preferably programmed to measure the evoked response plus polarization resulting from capture by a first stimulation pulse and subtracting from it a measured polarization in response to a second stimulation pulse delivered during a refractory period. The electrode configuration yielding the greatest difference may then be selected and programmed into the device. Thereafter, whenever evoked responses are to be sensed, the processor and a switch bank couple the best electrode configuration for sensing evoked responses to a sensing circuit.
REFERENCES:
patent: 4686988 (1987-08-01), Sholder
patent: 4708142 (1987-11-01), DeCote, Jr.
patent: 4712555 (1987-12-01), Thornander et al.
patent: 4729376 (1988-03-01), DeCote, Jr.
patent: 4940052 (1990-07-01), Mann et al.
patent: 4944298 (1990-07-01), Sholder
patent: 4969467 (1990-11-01), Callaghan et al.
patent: 4991583 (1991-02-01), Silvian
patent: 5003975 (1991-04-01), Hafelfinger et al.
patent: 5324310 (1994-06-01), Greenlinger et al.
patent: 5350410 (1994-09-01), Kleks et al.
patent: 5411528 (1995-05-01), Miller et al.
patent: 5466254 (1995-11-01), Helland
patent: 5855594 (1999-01-01), Olive et al.
patent: 6175766 (2001-01-01), Bornzin et al.
patent: 6263244 (2001-07-01), Mann et al.
Bornzin Gene A.
Florio Joseph J.
Mann Brian M.
Sholder Jason A.
Sloman Laurence S.
Jastrzab Jeffrey R.
Oropeza Frances P.
Pacesetter Inc.
LandOfFree
Implantable cardiac stimulation device with automatic evoked... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Implantable cardiac stimulation device with automatic evoked..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Implantable cardiac stimulation device with automatic evoked... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3281396